Trial Profile

Open Randomized Study Comparing Clinical Efficacy of Corifollitropin Alfa (Elonva) in Combination With Menotropin (Merional) With Follitropin and Lutropin Alfa (Pergoveris) for Ovarian Stimulation in Expected Suboptimal Responders

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 21 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Corifollitropin alfa (Primary) ; Follitropin alfa/lutropin alfa (Primary) ; Menotropin (Primary)
Indications Female infertility
Focus Therapeutic Use
Acronyms TEMPER

10 Sep 2019 Status changed from recruiting to completed.
08 Feb 2019 Planned End Date changed from 1 Sep 2018 to 1 Dec 2019.
08 Feb 2019 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com